Informe gratuito sobre el estado actual de la desalinización en América Latina

New York City, 6 de marzo de 2024 Obtenga el informe gratuito sobre el estado actual de la desalinización en América Latina Como preámbulo al 6to Congreso Desalinización América Latina  2024 que se celebrara la próxima semana en Santiago de Chile, los días 13 y 14 de marzo  de  2024, Vostock Capital se complace en […]

SKYX Enters Collaboration with Golden Lighting to Introduce Smart Plug & Play Products into Expanded Sales Channels

New York, March 06, 2024 – PRISM MediaWire – SKYX Platforms Corp. (Nasdaq: SKYX) announces a strategic partnership with Golden Lighting, a renowned manufacturer and premier provider of elegant lighting solutions. This collaboration aims to facilitate SKYX’s introduction of innovative smart and advanced plug & play products to a broader spectrum of online, builder, and professional clientele. Rani Kohen, […]

Free report about the status of the desalination industry in Latin America

New York City, March 06, 2024 Get the free report about status of desalination industry in Latin America As a preamble to the upcoming 6th Congress and Exhibition Desalination Latin America 2024, which will take place next week in Santiago de Chile on March 13th and 14th, Vostock Capital is pleased to share the results […]

DRYWORLD Brands (IBGR) Strategically Positions Itself for Game-Changing Impact in 2024 Following Dynamic Moves in 2023

New York, March 05, 2024 – PRISM MediaWire – Today, DRYWORLD Brands, Inc. ($IBGR), a leading global sports brand renowned for premium performance, delivered its annual corporate update to the investment community. The update showcased remarkable achievements, including a staggering 1700% surge in sales from Q1 2023 to 2024, the successful launch of 377 products within a span of […]

Lipella Pharmaceuticals Announces FDA Clearance of IND for LP-410 for Oral Graft-Versus-Host Disease, Advancing Clinical Pipeline

Clinical testing of LP-410 expected to commence in Q2 2024 Pittsburgh, PA, March 05, 2024 – Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announces that the U.S. Food and Drug Administration (FDA) has approved an Investigational New Drug (IND) […]

AB INTL Reports Forecast Revenues from Its Participated Chinese Market Film Sales

NEW YORK, March 4, 2024 – AB International Group Corp. (OTC: ABQQ) (“AB” or the “Company”), an intellectual property (IP) and movie investment and licensing firm, is pleased to announce update information that based on the information currently available to the Management, it is expected that the Company may record impressive revenues from Chinese market […]

FREEDOM HOLDINGS CORPORATE UPDATE: MANAGEMENT ANNOUNCES GLENDALE SECURITIES, INC. RECEIVED NOTIFICATION THAT THE FINRA REVIEW OF THE FORM 211 APPLICATION HAS BEEN COMPLETED

Freedom Holdings Receives Notice that FINRA has Completed the Form 211 Review Chatsworth, CA, March 04, 2024 – Freedom Holdings, Inc. aka Freedom Acquisition Corp (OTC: FHLD) (“FHLD” or the “Company”) is pleased to announce that Glendale Securities, Inc., received notice from FINRA that they have completed the Form 211 review. On 02/26/2024, FINRA processed […]

Auto Parts 4 Less Group Inc. Announces the Reactivation of LiftKits4Less.com to Accelerate Revenue Growth and Diversify Offerings

Las Vegas, NV, March 04, 2024 – Auto Parts 4 Less Group, Inc. (OTC Pink: FLES) (the “Company,” “Auto Parts4Less,” “FLES”), a leading online marketplace for automotive parts only, is excited to announce the reactivation of its specialized e-commerce website LiftKits4Less.com. This strategic move is aimed at accelerating the Company’s revenue model and diversifying its […]

PRISM MarketView Highlights Work of Emerging Companies on Rare Disease Day

New York, N.Y., February 29, 2024 – PRISM MarketView, a leading provider of unbiased market insight and company news, recognizes the remarkable contributions of companies developing treatments for the 10,000 rare diseases affecting more than 30 million Americans. All areas of medicine, and all organs and body systems, are impacted by rare diseases, including rare […]